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Abstract
Background: The proportion of women entering pregnancy overweight or obese has been rising and, in turn, is
associated with adverse maternal and fetal outcomes. Gestational weight gain (GWG) exceeding Institute of
Medicine (IOM) guidelines further increases health risks and has been independently associated with postpartum
weight retention. Hispanic women are disproportionately affected by overweight and obesity, but have had limited
access to interventions that promote healthy lifestyles due to cultural, socioeconomic, and language barriers. Therefore,
the overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified,
individually-tailored lifestyle intervention to reduce excess GWG, increase postpartum weight loss, and improve
maternal metabolic status among overweight/obese Hispanic women.
Methods/Design: Overweight/obese Hispanic women are recruited in early pregnancy and randomly assigned
to a Lifestyle Intervention (n = 150) or a Comparison Health and Wellness (control) intervention (n = 150). Multimodal
contacts (i.e., in-person, telephone counseling, and mailed print-based materials) are used to deliver the intervention
from early pregnancy (12 weeks gestation) to 6 months postpartum, with follow-up to 1 year postpartum. Targets of
the intervention are to achieve IOM Guidelines for GWG and postpartum weight loss; American Congress of
Obstetrician and Gynecologist guidelines for physical activity; and American Diabetes Association guidelines for diet.
The intervention draws from Social Cognitive Theory and the Transtheoretical Model and includes strategies to address
the specific social, cultural, and economic challenges faced by low-income Hispanic women. Assessments are
conducted at baseline (~10 weeks gestation), mid pregnancy (24–28 weeks gestation), late pregnancy (32–34 weeks
gestation) and postpartum at 6-weeks, 6-months, and 12-months by bicultural and bilingual personnel blinded to the
intervention arm. Efficacy is assessed via GWG, postpartum weight loss, and biomarkers of glycemic control, insulin
resistance, and cardiovascular disease risk factors. Changes in physical activity and diet are measured via 7-day
accelerometer data and 24-h dietary recalls at each assessment time period.
Discussion: Hispanic women are the fastest growing minority group in the U.S. and are disproportionately
affected by overweight and obesity. This randomised trial uses a high-reach, low-cost strategy that can readily be
translated into clinical practice in underserved and minority populations.
Trial registration: NCT01868230 May 29, 2013
Keywords: Lifestyle intervention, Randomised controlled trial, Healthy eating, Prevention, Diet, Latina, Physical
activity, Postpartum, Pregnancy, Gestational diabetes mellitus, Overweight, Obesity
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Background
Weight gain in women of reproductive age is increasing,
contributing to a rise in the proportion of women entering
pregnancy overweight or obese [1]. In turn, overweight
and obesity in pregnancy are established risk factors
for such maternal complications as cesarean delivery,
hypertension, gestational diabetes mellitus (GDM), and
preeclampsia [2–4]. Gestational weight gain (GWG)
exceeding Institute of Medicine (IOM) guidelines fur-
ther increases health risks and has been independently
associated with postpartum weight retention [5]. In
addition, recent reports indicate a relationship between
high GWG, an abnormal metabolic environment in utero,
increased risk of large-for-gestational-age (LGA) infants
[6], and subsequent childhood adiposity and morbidity [7].
In the United States, more than 40 % of pregnant
women exceed the Institute of Medicine (IOM) guide-
lines for GWG [1]. Studies have observed high rates of
excessive GWG among Hispanic women with, for ex-
ample, 52 % of overweight and 75 % of obese Hispanic
women having excessive GWG [8, 9]. This finding is
noteworthy as Hispanics are the largest minority group
in the U.S., with the highest birth and immigration
rates of any minority group [10]. Hispanics from the
Caribbean islands (i.e., Puerto Ricans and Dominicans)
are the 2nd largest group of Hispanics living in the
U.S.[10], the fastest growing subgroup, and the largest
Hispanic subgroup in the Northeast U.S.[11]. As com-
pared to other Hispanics, Puerto Ricans and Domini-
cans experience the greatest health disparities, the
highest prevalence of type 2 diabetes, and exhibit more
adverse behaviors such as poor nutrition [12–14]. Half
as many Hispanic women comply with recommenda-
tions for physical activity during pregnancy as com-
pared to non-Hispanic whites [15]. Hispanics are
disproportionately affected by overweight and obesity;
at each BMI level, Hispanics have a higher prevalence
of diabetes than non-Hispanic whites [16–18]. However,
due to cultural factors, socioeconomic circumstances, dif-
ferences in educational background, and language barriers,
Hispanics have had limited access to clinical and public
health interventions that promote healthy lifestyles.
The IOM has noted that existing research is inad-
equate to establish the characteristics of interventions
that work reliably to assist women in meeting guidelines
for GWG [1] and recent meta-analyses have been unable
to identify the defining features of effective interventions
[19, 20]. Interventions which begin during pregnancy
[21] may be more effective than those initiated only in
the postpartum period [22–24] given that it may be diffi-
cult to reduce postpartum weight retention without first
preventing excessive GWG during pregnancy [25]. There
is also evidence that both energy intake restriction and
physical activity are needed to reduce weight in the
postpartum period [23, 26] compared to exercise alone
[27]. Therefore, the overall objective of this trial is to test
the ability of a lifestyle intervention, informed by forma-
tive behavioral research, to reduce excess GWG, increase
postpartum weight loss, improve maternal metabolic sta-
tus among Hispanic women entering pregnancy over-
weight or obese Hispanic as well as to improve adiposity
measures among their offspring.
Aims
Specific aims for mothers are to achieve IOM Guidelines
for GWG, postpartum weight loss, and improve mater-
nal metabolic status by achieving and maintaining 1)
GWG within guidelines based on pre-pregnancy BMI
[1]; 2) a 5 % reduction from pre-pregnancy weight, 3) at
least 150 min per week of moderate intensity physical
activity such as brisk walking, as recommended by the
American Congress of Obstetrician and Gynecologists
(ACOG) [28], and 4) reduction in total energy intake by
following a balanced healthy diet as recommended by
American Diabetes Association (ADA) [29]. Specific
aims for offspring are to improve adiposity measures (i.e.,
weight, waist and head circumference, skinfold thick-
nesses, and fetal growth). The final aim evaluates the cost-
effectiveness of the lifestyle intervention (i.e., start-up
costs, total cost/participant, and ratio of average dollars
spent per average incremental improvement in outcome.
Methods
Proyecto Mamá is based at the ambulatory obstetrical prac-
tices of Baystate Medical Center in Western Massachusetts.
Eligible pregnant Hispanic women are recruited in early
pregnancy (~10 weeks gestation) and randomly assigned
to a Lifestyle Intervention (n = 150) or a Comparison
Health &Wellness (control) Intervention (n = 150) (Fig. 1).
Multimodal contacts (i.e., in-person, telephone counseling,
and mailed print-based materials) are used to deliver the
intervention from ~12 weeks gestation to delivery (Phase
1: Pregnancy Intervention) and from 6 weeks to 6 months
postpartum (Phase 2: Postpartum Intervention); follow-up
continues to 1 year postpartum (Fig. 1).
Eligibility criteria
Eligible women are pregnant Hispanic women who are
overweight or obese (BMI ≥ 25 kg/m2) and 18–45 years
of age. Women with the following characteristics are ex-
cluded: 1) pre-pregnancy BMI < 25 kg/m2, 2) history of
type 2 diabetes, heart disease, or chronic renal disease,
2) contraindications to participation in moderate phys-
ical activity or to a low-fat/high-fiber diet (e.g., Crohn’s
disease, ulcerative colitis), 3) inability to read English or
Spanish at a 6th grade level, 4) <16 or >45 years of age,
5) >16 weeks gestation, 6) current medications which
adversely influence glucose tolerance, 7) not planning to
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continue to term or deliver at the study site, or 8) non-
singleton pregnancy (e.g., twins, triplets, etc.).
Recruitment
The trial capitalizes on our experience with culturally
appropriate strategies for recruiting pregnant Hispanic
women in practice-based settings [30]. Specifically, bilin-
gual (Spanish and English) and bicultural health educators
recruit women at the first prenatal care visit (~10 weeks
gestation). Women are informed of the aims and proce-
dures of the project and asked to sign a written informed
consent form, as approved by the Institutional Review
Boards of the University of Massachusetts-Amherst and
Baystate Health. Upon enrollment, the baseline assess-
ment includes: 1) data collection of behaviors during preg-
nancy via standardized questionnaires, 2) measures of
physical activity via an ActiGraph GT3X-plus activity
monitor (Actigraph LLC, Pensacola, FL) to be worn on
the wrist for the next 7 days, 3) measures of dietary intake
via three unannounced 24-h dietary recalls over the fol-
lowing two-week period, and 4) laboratory measures of
biomarkers of glycemic control, insulin resistance, and
other cardiovascular disease risk factors via a study-specific
fasting blood sample. After completion of each assessment
and blood draw, participants receive a gift card.
Randomisation
Randomisation to the Lifestyle Intervention or to the Health
& Wellness (control) Intervention occurs at ~12 weeks
gestation, after completion of the baseline assessment.
Randomisation is stratified based on age (<30, ≥30 years)
and pre-pregnancy BMI (overweight ≥25- < 30 kg/m2
vs. obese ≥30 kg/m2). Within each strata, a blocked
randomization is used such that both treatment groups
are assigned an equal number of times in each set of 4
sequentially enrolled patients.
Lifestyle intervention
The Lifestyle Intervention is an evidence-based approach
utilizing culturally and linguistically modified, motiv-
ationally targeted, individually-tailored intervention ma-
terials developed in our prior randomised controlled
trials among Hispanics [31–38]. The intervention draws
from Social Cognitive Theory [39] and the Transtheore-
tical Model [40] and takes into account findings by our
research group on the specific social, cultural, economic,
and environmental resources, as well as challenges faced
by women of Hispanic backgrounds [41–43]. An initial
pilot study, Estudio Vida, conducted among 68 over-
weight and obese Hispanic women found that the life-
style intervention was feasible [44].
The Prenatal Phase (~12 weeks gestation - delivery)
(Fig. 1) starts with a face-to-face introductory session
building upon the usual prenatal care received by patients.
The goal of this phase is to optimize GWG; the health
educator sets a GWG goal based on pre-pregnancy BMI
and explains the importance of meeting weight gain guide-
lines. The weight-based curriculum focuses on periodic
weight monitoring, graphing and education. Participants
are provided with a digital scale and are encouraged to
weigh themselves at home daily and to chart their weight
on a grid weekly. Emphasis is placed on using the scale as
an important feedback and learning tool for how to better
regulate personal diet and exercise behaviors. Motivational
interviewing principles are used to identify and strengthen
women’s motivations for change.
The introductory session additionally includes admin-
istration of physical activity and dietary questionnaires
that facilitate tailoring the intervention. The Exercise
Tailoring Questionnaire consists of 3 measures: Stages
of Change for Physical Activity [45], Processes of Change
for Physical Activity [46], and Self-Efficacy for Physical
Activity [45]. Physical activity change is targeted via indi-
vidualized week-by-week goals that focus on increasing,
by 10 %, the time spent in moderate-intensity activity as
well as steps taken per day. Women choose which form
of safe activity they enjoy the most or can most readily
fit into their lifestyle, from dancing to walking in a shop-
ping mall to yard work. The accumulation of short bouts
of moderate activity (i.e., 10 min episodes) is encour-
aged. Pedometers and activity logs are provided for
women to monitor their activity. Based on responses to
the tailoring questionnaires, individually-tailored com-
puter Expert-System Feedback Reports [36, 38, 47, 48]
Fig. 1 Trial Design
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draw particular messages from a library of approximately
296 messages regarding motivation, self-efficacy, and
cognitive and behavioral strategies for exercise adoption.
Manuals matched to their stage of motivational readi-
ness focus on the benefits of exercise, building social
support for new behavioral patterns, and strategies for
overcoming barriers to exercise specific to low-income
Hispanic women. Tip Sheets include topics such as
stretching and exercising with baby (e.g., walking while
pushing a stroller).
The Diet Tailoring Questionnaire is a two-part survey
consisting of a checklist of high-calorie and lower-
calorie foods and beverages commonly consumed by the
target population. Respondents are asked to indicate the
frequency that they consume the various foods and to
rate their confidence (self-efficacy) in their ability to de-
crease high calorie and increase low calorie food con-
sumption. Dietary change is targeted by working toward
an ultimate goal of 1,500 calories per day (up to 2,000
for breastfeeding women who lose more than 2 lbs/week
over a 2 week period). Dietary goals are tailored to the
participant based on responses to the Diet Tailoring
Questionnaires, which take into consideration energy-
dense foods that the participant eats frequently and feels
confident that she is able to reduce or replace, and lower
calorie foods that the participant eats infrequently and
feels confident that she can increase. Participants are
instructed in how to self-monitor dietary intake using
the food calorie guide and a tip sheet for measuring por-
tion sizes. Participants are provided with measuring cups
and a dietary log.
The introductory session is followed over the remainder
of pregnancy by biweekly and monthly mailed, print-based
materials as well as telephone booster calls to provide
motivationally-based individualized feedback. Based on re-
sponses to monthly mailed tailoring questionnaires, cul-
turally and motivationally targeted individualized reports
are sent. All materials are written at a 6th grade reading
level in Spanish or English depending upon participant
preference. A third trimester face-to-face session (~34 weeks
gestation), with the goal of preparation for the Postpartum
Phase, targets knowledge and attitudes regarding postpar-
tum weight loss and type 2 diabetes prevention.
The Postpartum Phase (6 weeks postpartum – 6 months
postpartum) (Fig. 1) starts with a face-to-face session.
The tailoring questionnaires are repeated and physical
activity goals, dietary goals, and a weight loss goal,
based on pre-pregnancy BMI, are set. Participants are
encouraged to work toward this goal by focusing on a
reduction of 1–2 pounds per week. The health educa-
tor utilizes a checklist of motivators for weight loss
specific to new mothers, to help women identify their
own weight loss motivations and to reinforce engage-
ment. Participants are, again, encouraged to weigh
themselves at home daily and to chart their weight on
a grid weekly.
This postpartum session is followed by monthly mailed,
print-based materials as well as telephone booster calls to
provide motivationally-based individualized feedback.
Booster telephone sessions facilitate: 1) review of progress
toward dietary, physical activity and weight loss goals, 2)
problem-solving of challenges faced in achieving goals
(e.g., balancing caregiver/household responsibilities, cul-
tural norms of self-sacrifice, limited social support, partner
negotiation, and neighborhood safety), 3) discussion of
mailed tip sheets, and 4) assistance with setting new goals.
Quality control procedures ensure that stage of change
and social cognitive constructs are consistently repre-
sented in all intervention materials.
Health & wellness (Control) intervention
To ensure retention and to control for contact time, the
Health & Wellness (control) arm receives mailed health
materials and telephone booster calls at the same fre-
quency as the Lifestyle Intervention arm. Mailed mate-
rials focus on non-exercise and non-dietary topics and
include booklets from ACOG and the American Acad-
emy of Pediatrics in English or Spanish. These booklets
represent high-quality, standard, low-cost, self-help ma-
terial currently available to the public. In this way, we
control for contact time, while keeping the content of
the two interventions distinct. Hispanic control-arm par-
ticipants in our prior studies reported that these mate-
rials were of interest and differential dropout did not
occur between study arms [35, 49].
Outcome variables
GWG is calculated as the difference between maternal
weight at delivery and pre-pregnancy weight; rate of
weight gain is calculated as GWG divided by gestational
age at delivery in weeks. Compliance with IOM weight
gain guidelines is calculated by comparing the observed
weight gain with the 2009 IOM Guidelines [1]. Postpar-
tum weight loss is measured as the difference between
weight at 6 or 12 months postpartum and weight at deliv-
ery, and calculated as absolute weight change according to
pre-pregnancy BMI, percentage who retain a specific
amount of weight over pre-pregnancy weight, or propor-
tion whose BMI category changes from pre-pregnancy
BMI category (Table 1).
Fasting maternal biomarkers are collected at baseline
(~10 weeks gestation), mid pregnancy (24–28 weeks ges-
tation), late pregnancy (32–34 weeks gestation) and post-
partum at 6-weeks, 6-months, and 1-year (Table 1).
Biomarkers of glycemic control and insulin resistance in-
clude glucose, insulin, HbA1c, homeostasis model assess-
ment (HOMA), leptin, and adiponectin. Postpartum
biomarkers of cardiovascular risk include total cholesterol,
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Table 1 Variables collected at assessment timepoints
Pregnancy Delivery Postpartum
10 weeks 24-28 weeks 32-34 weeks 6 weeks 6 months 1 year
Aim #1: Gestational Weight Gain (GWG) and Postpartum Weight Loss
GWG (kg) X X X X
Rate of GWG X X X X
Compliance with IOM guidelines X X X X
Area under the GWG curve (AUC) X X X X
Postpartum weight loss X X X X X
Physical activity (actigraph, PPAQ) X X X X X X
Dietary intake (Hispanic FFQ) X X X X X X
Aim #2: Glycemia and Associated Biomarkers of Insulin Resistance
Glucose (mg/dl) X X X X X X
Insulin (pmol/l) X X X X X X
Hb A1 c (%) X X X X X X
Adiponectin (μg/ml) X X X X X X
Leptin (ng/ml) X X X X X X
HOMA X X X X X X
Aim #3: Postpartum Biomarkers of Cardiovascular Disease Risk
Total cholesterol (mg/dL) X X X X
Triglycerides (mg/dL) X X X X
HDL-cholesterol (mg/dL) X X X X
LDL-cholesterol (mg/dL) X X X X
Systolic blood pressure (mm Hg) X X X X X X
Diastolic blood pressure (mm Hg) X X X X X X
hsCRP (mg/dl) X X X X
Aim #4: Offspring Outcomes
Birthweight-for-gestational age z-score [fetal growth] X
Ponderal Index (g/cm3) X X X X
Weight-for-length z-score (WFL-z) X X X X
Weight-for-age z-score (WFA-z) X X X X
Length-for-age z score (LFA-z) X X X X
Sum of skinfolds, ratio of skinfolds X X X X
Waist circumference (cm) X X X X
Head circumference (cm) X X X X
C
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Table 1 Variables collected at assessment timepoints (Continued)
Aim #5: Cost Effectiveness Variables
Star-up costs, total cost/participant X X X X X X X
Avg $/avg incremental improvement X X X X X X X
Covariates
Clinical characteristics of current pregnancy X X X
Medical history X
Sociodemographic factors X
Smoking (cotinine) and substance use X X X X X X
Depression X X X X X X
Sleep X X X X X X
Breastfeeding X X X
Social Support X X X X X X
C
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LDL-cholesterol, HDL-cholesterol, triglyceride concentra-
tions, systolic and diastolic blood pressure, and C-reactive
protein (CRP). Postpartum diabetes screening occurs at
each postpartum assessment and follows the guidelines of
the 2007 5th International Workshop Conference on
GDM recommending a postpartum 75-g OGTT [50]
using diagnostic criteria defined by the American Diabetes
Association [51].
Child anthropometric measures are obtained within
24 h of delivery, 6 weeks, 6 months, and 1 year postpar-
tum and include measured weight on a calibrated scale,
length using a measuring board, waist and head circum-
ference, and subscapular (SS) and triceps (TR) skinfold
thicknesses. Fetal growth is calculated as birthweight-
for-gestational age z-score and ponderal index (PI) as
birth weight (g) x 100/birth length (cm)3. Change from 0
to 6 months and from 0 to 12 months in weight-for-
length z-score (WFL-z), weight-for-age z-score (WFA-z),
and length-for-age z-score (LFA-z) are calculated. Age-
and sex-specific scores are calculated using U.S. national
reference data (National Center for Health Statistics,
CDC Growth Charts).
Behavioral outcomes
Women are provided with an accelerometer, the Acti-
Graph GT3X-plus, to be worn on the wrist for 7-days at
each of the assessment time periods (baseline, mid preg-
nancy, late pregnancy, and postpartum at 6-weeks, 6-
months, and 12-months). Previous studies have reported
reasonable validity under laboratory conditions among
pregnant women [52], as well as under free-living condi-
tions [53–55]. In addition, at each assessment time period,
trained bilingual personnel blinded to the assigned inter-
vention arm conduct three unannounced 24-h dietary
recalls over a two-week period and administer the Preg-
nancy Physical Activity Questionnaire (PPAQ) [56]. The
PPAQ is a semi-quantitative questionnaire, which evalu-
ates participation in household/caregiving, occupational,
sports/exercise, and transportation activities.
Covariates
Clinical characteristics of the current pregnancy and
medical history are abstracted from the pregnancy med-
ical record (Table 1). Weight is measured prospectively
at each prenatal visit and postpartum weight is measured
during assessment visits by trained study staff to the
nearest 0.1 kg on accurately calibrated standard clinical
scales using a standardized protocol. Gestational age is
based upon the best clinical estimate as recorded in the
medical record. Gestational age at the time of GDM
screen, degree of abnormality on glucose tolerance test-
ing during pregnancy, treatment for glucose abnormality
during pregnancy (e.g., diet, oral hypoglycemic agents
and/or insulin), pregnancy complications and birth out-
comes are abstracted from the medical record.
Sociodemographic factors are collected via self-report
at enrollment. Acculturation is assessed via the Psycho-
logical Acculturation Scale [57], language preference,
and generation in the U.S. Smoking is assessed via the
biomarker cotinine. Social support for diet and exercise
is measured via the Social Support for Diet and Exercise
Behaviors (SSDEB) questionnaire during pregnancy and
postpartum [58]. Additional factors collected at each
postpartum assessment include: The Pittsburgh Sleep
Quality Index (PSQI) [59], the Edinburgh Postpartum
Depression Scale [60, 61], and the Infant Feeding Ques-
tionnaire [62].
Data analysis
Primary analyses will evaluate differences in the change
from baseline in weight gain measures, glycemic control
and other biomarkers of insulin resistance and cardio-
vascular risk factors between the groups (an intent-to-
treat analysis). We will use mixed models with random
subject effects, including a common mean at baseline
for the treatment groups, a period effect, and an inter-
vention by period interaction [63]. The mixed model
analysis will enable inclusion of time varying covariates
such as breastfeeding behaviors, depression, and sleep,
which may vary between baseline and follow-up for indi-
viduals. Equivalence of treatment groups will be assessed
by comparing distributions of the potential confounders
across groups. In addition, we will investigate established
risk factors for weight gain (e.g., parity) and glycemic
control as well as degree and treatment for abnormality
on glucose tolerance testing during pregnancy (e.g., diet,
oral hypoglycemic and/or insulin) as potential con-
founders or effect modifiers. Mixed model analyses will
also be used to account for the repeated measures of ex-
ercise and diet and will be used to evaluate adoption and
maintenance of behavior change in the Lifestyle Inter-
vention group.
We will evaluate the impact of intervention arm on
the offspring outcomes using the methods described
above. We will also examine GWG and prenatal gly-
cemic factors as predictors of weight gain in early in-
fancy and childhood. In models focused on offspring
weight gain as the outcome, we will additionally adjust
for fetal growth (i.e., BW/GA z-score).
Power and sample size
The study is powered to detect mean differences in
change in outcome variables from baseline in the Life-
style Intervention as compared to the Health and Well-
ness (control) Intervention that are equivalent to 0.35 to
0.40 standard deviations, or a “small-medium” effect size
[64] at 80 % power at a 0.05 level of significance. Based
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on observed rates in our prior and ongoing trials [44, 65],
we conservatively expect 10 % of women to leave the
area, deliver elsewhere, or withdraw during pregnancy,
and therefore plan to recruit 333 women to achieve our
goal of 300 participants (150 in each intervention arm)
at the time of delivery. Based on this sample size, we
have 80 % power to detect as small as a 2.4 % difference
in percent change in HbA1c between treatment arms
and 80 % power to detect a 30 % reduction in risk for
exceeding IOM guidelines.
For offspring outcomes, we calculate that 4 % will be
excluded for very early preterm birth (<34 weeks), mis-
carriage, or stillbirth resulting in 288 children at delivery.
For postpartum outcomes, over the following postpar-
tum year, we conservatively project that an additional
8 % of women will be lost to follow-up due to with-
drawal or movement out of the area. Women who be-
come pregnant again will be censored. Therefore, we
expect 264 women and children at 1 year postpartum.
This provides us with the ability to detect 0.35 to 0.40
standard deviations, or a “small-medium” effect size [64]
at 80 % power at a 0.05 level of significance for postpar-
tum weight loss, maternal biomarkers of glycemic con-
trol, insulin resistance, and cardiovascular disease risk
factors, and offspring adiposity measures at one year
postpartum.
Discussion
This trial is innovative in testing a prenatal and postpar-
tum lifestyle intervention designed to reduce excess
GWG, increase postpartum weight loss, and improve
maternal metabolic status among overweight/obese His-
panic women. Strengths of the study include a culturally
specific exercise and dietary intervention delivered via a
combination of modalities including in-person, mail,
telephone; individualized diet and physical activity goals;
the use of psychological theory to drive the intervention;
prior experience with recruitment and follow-up in the
study population; multidimensional (subjective and ob-
jective) measures of physical activity and diet validated
in the study population; measures of adiposity in
addition to weight; and multiple and fasting measures of
serum biomarkers of insulin resistance. Other advances
include: 1) inclusion of a significant proportion of low in-
come women, 2) randomization to a Lifestyle Intervention
or a comparison Health & Wellness arm, thereby control-
ling for contact time; 3) a translatable intervention feasible
for primary healthcare providers; and 4) follow-up from
pregnancy through the postpartum period allowing the
evaluation of both maternal and offspring outcomes.
Women receive closer medical attention during the
prenatal and postpartum periods than at other times in
their adult lives, and are often highly motivated to improve
their health to benefit themselves and their children. This
pregnancy and postpartum lifestyle intervention capital-
izes upon these teachable moments [66].
The low-income Hispanic population targeted by this
study will include Spanish speakers (~25 %), a population
who have, overall, been excluded from research studies
[67] or are underrepresented in research even when re-
cruitment goals include Hispanics [68] despite the greater
health challenges they face. The trial includes novel mate-
rials developed specifically for this group, thus increasing
its innovation.
Investigation of which types of programs benefit preg-
nant and postpartum women, and identification of
women at particularly high-risk, are needed to increase
the effectiveness of any prevention efforts. Changes in
lifestyle risk factors (e.g., regular exercise, healthy diet)
among overweight and obese Hispanic women may re-
duce risk of obesity and subsequent type 2 diabetes and
CVD for both mother and offspring. The public health im-
pact of such lifestyle modifications is likely to be greatest
in ethnic groups, such as Hispanics, with a consistently
high prevalence of obesity, diabetes, and the highest preva-
lence of sedentary behavior. This randomised controlled
trial uses a high-reach, low-cost strategy, which can readily
be translated into clinical practice in underserved and mi-
nority populations.
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